BIM
GHDX

Bogle Investment Management’s Genomic Health, Inc. GHDX Stock Holding History

Bogle Investment Management’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-25,084
Closed -$1.46M – 357
2019
Q2 		$1.46M Sell
25,084
-160,341
-86% -$9.5M 0.11% 164
2019
Q1 		$13M Buy
185,425
+20,115
+12% +$1.49M 0.99% 23
2018
Q4 		$10.6M Buy
165,310
+80,532
+95% +$5.65M 0.83% 47
2018
Q3 		$5.95M Sell
84,778
-23,538
-22% -$1.38M 0.43% 84
2018
Q2 		$5.46M Buy
108,316
+43,970
+68% +$1.74M 0.39% 93
2018
Q1 		$2.01M Buy
+64,346
New +$2.13M 0.15% 149
2017
Q4 		– Sell
-44,405
Closed -$1.42M – 394
2017
Q3 		$1.42M Sell
44,405
-16,136
-27% -$509K 0.1% 181
2017
Q2 		$1.97M Buy
60,541
+12,162
+25% +$385K 0.14% 151
2017
Q1 		$1.52M Sell
48,379
-54,883
-53% -$1.62M 0.11% 171
2016
Q4 		$3.03M Buy
103,262
+32,554
+46% +$992K 0.21% 144
2016
Q3 		$2.04M Buy
+70,708
New +$1.97M 0.15% 162

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Bogle Investment Management's GHDX Position: Q3 2019 in Review

Bogle Investment Management sold out of Genomic Health, Inc. (GHDX) in Q3 2019, closing a stake of 25,084 shares — an estimated $1.46M sold.

Bogle Investment Management first reported a position in GHDX in Q3 2016 and held it in 11 quarters. The position peaked at $13M in Q1 2019. 221 funds tracked by Wall St. Rank hold GHDX as of Q3 2019.

  • Bogle Investment Management reported no remaining Genomic Health, Inc. position as of Q3 2019 after selling out during the quarter.
  • Bogle Investment Management sold 25,084 Genomic Health, Inc. shares in Q3 2019, an estimated $1.46M.
  • Bogle Investment Management first reported a position in Genomic Health, Inc. in Q3 2016 and held it in 11 quarters.
  • Bogle Investment Management's Genomic Health, Inc. position peaked at $13M in Q1 2019.
  • 221 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q3 2019.

Based on Bogle Investment Management's 13F filing for Q3 2019, filed 13 Nov 2019.